|Articles|May 1, 2016
- Pharmaceutical Executive-05-01-2016
- Volume 36
- Issue 5
Pharmaceutical Executive, May 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Steering the Change: GSK's Jack Baileyover 9 years ago
Pharma’s Big Push for Valueover 9 years ago
Pharm Exec at the Vantage Pointover 9 years ago
Pharma Under Pressure to Curb Opioid Abuseover 9 years ago
Country Report: Franceover 9 years ago
Pharma Under Fire for Driving "Opioid Abuse Epidemic"Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
3
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
4
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
5
